CGD Policy Blogs
Gordon Brown, the UK Finance Minister, presented his tenth annual budget today. It included a strong commitment to Advance Market Commitments. From Chapter 5 of the report:
Today's New York Times (free registration required) discusses whether the lesson of the campaign to eradicate polio is that it is more effective to control than to try to eradicate diseases:
Today the struggling drive against polio has raised new questions about whether eradication of any disease is achievable, and, if so, whether the cost in terms of effort and dollars would be worth it, given all the other diseases that need attention.
Health and Human Services (HHS) Secretary Mike Leavitt reported this week on preparations for a possible influenza pandemic, promised to act soon to boost US flu vaccine production capacity and promote cell-based vaccine technology.
EMERYVILLE, Calif. Biotech company Chiron is recalling a vaccine used to combat measles, mumps and rubella.
The Emeryville-based company says it distributed about five million doses of what it calls the Morupar vaccine to developing countries in 2005. Another 450-thousand doses were distributed in Italy.
The Meningitis Vaccine Project has completed the Phase I clinical trial of a new vaccine against serogroup A meningococcus. Meningitis, an infection of the the thin lining that surrounds the brain and spinal cord, is fatal in 10% of its victims and permanently disables another 20% - even if they have received antibiotic treatment.
Robert F Kennedy writes about the Thimerosal controversy, and says that the WHO has pushed the CDC to disguise the dangers.
The US Postal Service announced yesterday the issue of stamps to honor heroes of the vaccine world:
Two of the most esteemed scientists in the world, Dr. Jonas Salk and
Dr. Albert Sabin, were honored today with postage stamps as part of the
Distinguished Americans series. For their dedication to fighting polio
and other infectious diseases, Salk and Sabin received numerous awards,
including the Presidential Medal of Freedom (Salk in 1977, Sabin in
Former President Carter, keynote speaker yesterday for the dedication
of a new biomedical research building on the University of Washington
campus, said one reason he came to Seattle was to make sure his "friend
and mentor" Dr. Bill Foege did not this time escape public recognition. ...